Evidence map›Paper›PMID 35596193›Full record

Trial reportBMC psychology2022

Talking control sessions in people with advanced cancer: a qualitative analysis of sessions.

Daphne Lamirel, Sarah Davis, Joe Low, Marc Serfaty, Megan Armstrong

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Daphne LamirelDivision of Psychiatry, University College London, 149 Tottenham Court RD, London, W1T 7NF, UK.
Sarah DavisDivision of Psychiatry, University College London, 149 Tottenham Court RD, London, W1T 7NF, UK.
Joe LowPrimary Care and Population Health, University College London, Royal Free Campus, Rowland Hill St, London, NW3 2PF, UK.
Marc SerfatyDivision of Psychiatry, University College London, 149 Tottenham Court RD, London, W1T 7NF, UK.
Megan ArmstrongPrimary Care and Population Health, University College London, Royal Free Campus, Rowland Hill St, London, NW3 2PF, UK. Megan.armstrong@ucl.ac.uk.
Total (United Kingdom) · GBUniversity College London · GBRoland Hill (United Kingdom) · GB

Funding

Marie Curie MCCC-FCO-11-UNational Institute for Health Research: Research for Patient Benefit PB-PG-1111-26043
6 · The paper itself

Abstract

backgroundTalking control (TC) was developed to control for the common factors in therapy so that the specific effects of therapy can be tested. A TC was recently used in a pilot study of Acceptance and Commitment therapy for dysfunction in people with advanced cancer. This work explores the audio recording of the sessions in a TC to explore how they were utilised by people with advanced cancer.

methodsThis is a qualitative study nested in larger feasibility randomised control trial. The trial participants were recruited from three London hospices. The study examined data for 5 participants who received weekly sessions of a TC. Fifteen sessions, three per participant, were transcribed and analysed using a thematic approach.

resultsIndividuals with advanced cancer used TC sessions as a safe place in which they could express their feelings-from smaller daily concerns to deeper-rooted difficulties. Many participants also engaged in emotional and cognitive avoidance regarding some topics, particularly those pertaining to their cancer. The TC sessions were also used as an opportunity to focus on the more positive aspects of their lives. Lastly, they served to reflect on ways to overcome difficulties.

conclusionsThis study suggests the TC can have beneficial, albeit varying uses for people with advanced cancer, that may even be considered therapeutic.

Indexed as

Acceptance and Commitment TherapyNeoplasmsCost-Benefit AnalysisHumansPilot ProjectsAdvanced cancerControl groupPsychotherapyQualitativeTalking control

Identifiers

PMID35596193
PMCPMC9121545
OpenAlexW4280529793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.